Evidence map›Paper›PMID 28978467›Full record

ArticleCell reports2017

M. tuberculosis-Initiated Human Mannose Receptor Signaling Regulates Macrophage Recognition and Vesicle Trafficking by FcRγ-Chain, Grb2, and SHP-1.

Murugesan V S Rajaram, Eusondia Arnett, Abul K Azad, Evelyn Guirado, Bin Ni, Abigail D Gerberick, Li-Zhen He, Tibor Keler, Lawrence J Thomas, William P Lafuse and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 141 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Phagocytosis at a glance.Journal of cell science · 2025
    Review
  10. Integrative transcriptome-based drug repurposing in tuberculosis.bioRxiv : the preprint server for biology · 2025
    Article
  11. Exploiting thioether reactivity to label mycobacterial glycans.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Murugesan V S RajaramCenter for Microbial Interface Biology, The Ohio State University, Columbus, OH 43210, USA; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA. Electronic address: murugesan.rajaram@osumc.edu.
Eusondia ArnettCenter for Microbial Interface Biology, The Ohio State University, Columbus, OH 43210, USA; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA.
Abul K AzadCenter for Microbial Interface Biology, The Ohio State University, Columbus, OH 43210, USA; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA.
Evelyn GuiradoCenter for Microbial Interface Biology, The Ohio State University, Columbus, OH 43210, USA; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA.
Bin NiCenter for Microbial Interface Biology, The Ohio State University, Columbus, OH 43210, USA; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA; Medical Scientist Training Program, The Ohio State University, Columbus, OH 43210, USA.
Abigail D GerberickCenter for Microbial Interface Biology, The Ohio State University, Columbus, OH 43210, USA.
Li-Zhen HeCelldex Therapeutics, Inc., Needham, MA 02723, USA.
Tibor KelerCelldex Therapeutics, Inc., Needham, MA 02723, USA.
Lawrence J ThomasCelldex Therapeutics, Inc., Needham, MA 02723, USA.
William P LafuseCenter for Microbial Interface Biology, The Ohio State University, Columbus, OH 43210, USA; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA.
Larry S SchlesingerCenter for Microbial Interface Biology, The Ohio State University, Columbus, OH 43210, USA; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, USA. Electronic address: lschlesinger@txbiomed.org.
Interface (United States) · USCelldex Therapeutics (United States) · USThe Ohio State University · US

Funding

TB and Innate Immune Regulation of Lung MacrophagesR01AI059639 · NIAID · OHIO STATE UNIVERSITY · PI SCHLESINGER, LARRY S. · 2005 to 2016
$3.2M
TB and Innate Immune Regulation of Lung MacrophagesR21AI059639 · NIAID · OHIO STATE UNIVERSITY · PI SCHLESINGER, LARRY S. · 2004 to 2004
$299k
NIAID NIH HHS R01 AI059639NIAID NIH HHS R21 AI059639
6 · The paper itself

Abstract

Despite its prominent role as a C-type lectin (CTL) pattern recognition receptor, mannose receptor (MR, CD206)-specific signaling molecules and pathways are unknown. The MR is highly expressed on human macrophages, regulating endocytosis, phagocytosis, and immune responses and mediating Mycobacterium tuberculosis (M.tb) phagocytosis by human macrophages, thereby limiting phagosome-lysosome (P-L) fusion. We identified human MR-associated proteins using phosphorylated and non-phosphorylated MR cytoplasmic tail peptides. We found that MR binds FcRγ-chain, which is required for MR plasma membrane localization and M.tb cell association. Additionally, we discovered that MR-mediated M.tb association triggers immediate MR tyrosine residue phosphorylation and Grb2 recruitment, activating the Rac/Pak/Cdc-42 signaling cascade important for M.tb uptake. MR activation subsequently recruits SHP-1 to the M.tb-containing phagosome, where its activity limits PI(3)P generation at the phagosome and M.tb P-L fusion and promotes M.tb growth. In sum, we identify human MR signaling pathways that temporally regulate phagocytosis and P-L fusion during M.tb infection.

Indexed as

Host-Pathogen Interactionscdc42 GTP-Binding ProteinGene Expression RegulationGRB2 Adaptor ProteinHumansLectins, C-TypeLysosomesMacrophagesMannose-Binding LectinsMannose ReceptorMembrane FusionMycobacterium tuberculosisp21-Activated KinasesPhagocytosisPhagosomesPhosphorylationcdc42 GTP-Binding ProteinCDC42 protein, humanGRB2 Adaptor ProteinGRB2 protein, humanLectins, C-TypeMannose-Binding LectinsMannose Receptorp21-Activated KinasesProtein Tyrosine Phosphatase, Non-Receptor Type 6rac GTP-Binding ProteinsReceptors, Cell SurfaceReceptors, IgGTyrosineC-type lectinhuman macrophagelysosomemannose receptorMycobacteriumphagosometuberculosis

Identifiers

PMID28978467
PMCPMC5960073
OpenAlexW2760970111

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.